BioSpace News Archive

Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on oncology and rare diseases, today announced the pricing of an underwritten public offering of 34,500,000 American Depositary Shares (“ADSs”) at a public offering price of $2.90 per ADS.

Notch Therapeutics announced today the closing of an oversubscribed U.S. $85 million Series A financing.

PolyPid Ltd. (Nasdaq: PYPD), a late-stage biopharma company aiming to improve surgical outcomes through locally administered, controlled, extended-release therapeutics, today provided a corporate update and reported financial results for the three months and full-year ended December 31, 2020.

Ortho Regenerative Technologies Inc . ( CSE: ORTH) (OTCQB: ORTIF ) a clinical stage orthobiologics company focused on the development of novel soft tissue repair regenerative technologies, announced today the launch of a 12-month online investors outreach campaign through AGORA

Visby Medical™ announced the US Food and Drug Administration authorized Visby’s rapid PCR COVID-19 test for use at the point of care.

Illumina, Inc. announced that its executives will be speaking at the following investor conferences and invited investors to participate via webcast.

Sema4, an AI- and machine learning-driven patient-centered genomic and clinical data intelligence company, and CM Life Sciences (Nasdaq: CMLF), a special purpose acquisition company, or SPAC, sponsored by affiliates of Casdin Capital, LLC and Corvex Management LP, today announced they have entered into a definitive business combination agreement.

IQVIA Reports Fourth-Quarter and Full-Year 2020 Results Raises Full-Year 2021 Guidance Revenue of $3,298 million for the fourth quarter grew 13.9 percent year-over-year Adjusted EBITDA of $735 million for the fourth quarter increased 14.5 percent year-over-year

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today reported results for the year and the quarter ended December 31, 2020.

Ciox Health, a leading health technology company, today announced a strategic collaboration between its Real World Data (RWD) Division and HealthVerity, the leader in privacy-protected data exchange